Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NAV1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of NAV1 mRNA | CTD | PMID:29097150 | 17beta-estradiol | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of NAV1 mRNA | CTD | PMID:30165855 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Metribolone results in decreased expression of NAV1 mRNA | CTD | PMID:16751804 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAV1 mRNA | CTD | PMID:17555868 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NAV1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NAV1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAV1 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NAV1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAV1 mRNA | CTD | PMID:19933214 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of NAV1 mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NAV1 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of NAV1 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NAV1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | affects methylation | EXP | | 6480464 | bisphenol S affects the methylation of NAV1 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of NAV1 protein | CTD | PMID:34186270 | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of NAV1 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | Decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of NAV1 mRNA] | CTD | PMID:28458013 | aflatoxin B1 | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of NAV1 mRNA] | CTD | PMID:28458013 | aflatoxin B1 | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of NAV1 mRNA | CTD | PMID:28458013 and PMID:32234424 | aflatoxin B1 | increases methylation | ISO | NAV1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of NAV1 gene | CTD | PMID:28458013 | aflatoxin B1 | decreases methylation | ISO | NAV1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of NAV1 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of NAV1 mRNA | CTD | PMID:21934132 | amphetamine | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of NAV1 mRNA | CTD | PMID:30779732 | antimycin A | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | antirheumatic drug | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of NAV1 mRNA | CTD | PMID:24449571 | arsane | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of NAV1 mRNA | CTD | PMID:19654921 | arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of NAV1 mRNA | CTD | PMID:19654921 | arsenite(3-) | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | arsenite results in decreased expression of NAV1 mRNA | CTD | PMID:23974009 | atrazine | affects methylation | ISO | Nav1 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of NAV1 gene | CTD | PMID:35440735 | benzo[a]pyrene | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of NAV1 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | affects methylation | ISO | NAV1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of NAV1 3' UTR more ... | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Soot co-treated with Benzo(a)pyrene] results in decreased expression of NAV1 protein modified form | CTD | PMID:24464499 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of NAV1 mRNA] | CTD | PMID:22228805 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of NAV1 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of NAV1 mRNA | CTD | PMID:29097150 | bisphenol A | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of NAV1 protein | CTD | PMID:34186270 | bisphenol A | decreases methylation | ISO | NAV1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of NAV1 gene | CTD | PMID:31601247 | bisphenol A | affects expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of NAV1 mRNA | CTD | PMID:30816183 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of NAV1 promoter | CTD | PMID:27312807 | bisphenol F | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA | CTD | PMID:28628672 | buta-1,3-diene | decreases expression | EXP | | 6480464 | 1 and 3-butadiene results in decreased expression of NAV1 mRNA | CTD | PMID:29038090 | butanal | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of NAV1 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NAV1 mRNA | CTD | PMID:35301059 | cadmium dichloride | increases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of NAV1 mRNA | CTD | PMID:33453195 | cadmium dichloride | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NAV1 mRNA | CTD | PMID:35301059 | calcitriol | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of NAV1 mRNA | CTD | PMID:16002434 | CGP 52608 | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to NAV1 gene] | CTD | PMID:28238834 | chlordecone | increases expression | EXP | | 6480464 | Chlordecone results in increased expression of NAV1 mRNA | CTD | PMID:33711761 | cisplatin | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of NAV1 mRNA | CTD | PMID:19561079 and PMID:27392435 | cisplatin | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of NAV1 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of NAV1 mRNA | CTD | PMID:19320972 | colforsin daropate hydrochloride | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Colforsin results in decreased expression of NAV1 mRNA | CTD | PMID:16751804 | copper atom | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of NAV1 mRNA | CTD | PMID:31162603 | copper(0) | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of NAV1 mRNA | CTD | PMID:31162603 | DDT | increases methylation | ISO | Nav1 (Rattus norvegicus) | 6480464 | DDT results in increased methylation of NAV1 gene | CTD | PMID:30207508 | deguelin | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | deguelin results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of NAV1 mRNA | CTD | PMID:22733784 | dexamethasone | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NAV1 mRNA | CTD | PMID:28628672 | dexamethasone | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of NAV1 mRNA | CTD | PMID:25047013 | dorsomorphin | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of NAV1 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of NAV1 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | entinostat | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | entinostat results in increased expression of NAV1 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of NAV1 mRNA | CTD | PMID:30319688 | fenpyroximate | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | fenpyroximate results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | FR900359 | affects phosphorylation | ISO | NAV1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of NAV1 protein | CTD | PMID:37730182 | gentamycin | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of NAV1 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NAV1 mRNA | CTD | PMID:28628672 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NAV1 mRNA | CTD | PMID:36331819 | lidocaine | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Lidocaine results in decreased expression of NAV1 mRNA | CTD | PMID:35283115 | lipopolysaccharide | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NAV1 mRNA | CTD | PMID:35811015 | mercury dibromide | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of NAV1 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | methoxychlor | affects methylation | ISO | Nav1 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of NAV1 gene | CTD | PMID:35440735 | methylmercury chloride | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of NAV1 mRNA | CTD | PMID:23179753 more ... | methylmercury chloride | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of NAV1 mRNA | CTD | PMID:28001369 | methylmercury chloride | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV1 mRNA | CTD | PMID:27188386 | morphine | decreases expression | EXP | | 6480464 | Morphine results in decreased expression of NAV1 mRNA | CTD | PMID:21178816 | nickel atom | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Nickel results in increased expression of NAV1 mRNA | CTD | PMID:25583101 | panobinostat | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of NAV1 mRNA | CTD | PMID:26272509 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of NAV1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of NAV1 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of NAV1 mRNA | CTD | PMID:29067470 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NAV1 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of NAV1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | picoxystrobin | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | pyrimidifen | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | pyrimidifen results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | rotenone | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NAV1 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | silicon dioxide | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of NAV1 mRNA | CTD | PMID:25895662 | sodium arsenate | increases expression | EXP | | 6480464 | sodium arsenate results in increased expression of NAV1 mRNA | CTD | PMID:21795629 | sodium arsenite | increases stability | ISO | NAV1 (Homo sapiens) | 6480464 | sodium arsenite results in increased stability of NAV1 mRNA | CTD | PMID:25493608 | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV1 mRNA | CTD | PMID:21641980 | sunitinib | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of NAV1 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of NAV1 mRNA | CTD | PMID:31758290 | thifluzamide | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | thifluzamide results in decreased expression of NAV1 mRNA | CTD | PMID:33512557 | thioacetamide | increases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of NAV1 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of NAV1 mRNA | CTD | PMID:29264374 | trichostatin A | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of NAV1 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of NAV1 mRNA | CTD | PMID:24935251 and PMID:26272509 | triclosan | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of NAV1 mRNA | CTD | PMID:30510588 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of NAV1 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | troglitazone results in increased expression of NAV1 mRNA | CTD | PMID:19140230 | valproic acid | affects expression | ISO | NAV1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NAV1 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | Nav1 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of NAV1 mRNA | CTD | PMID:29427782 | valproic acid | affects splicing | ISO | Nav1 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of NAV1 mRNA | CTD | PMID:29427782 | valproic acid | increases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NAV1 mRNA | CTD | PMID:24935251 | valproic acid | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NAV1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of NAV1 mRNA | CTD | PMID:26272509 | vorinostat | multiple interactions | ISO | NAV1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA | CTD | PMID:27188386 | zoledronic acid | decreases expression | ISO | NAV1 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of NAV1 mRNA | CTD | PMID:24714768 | | |||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Phenotype Annotations Click to see Annotation Detail View
Mammalian Phenotype
Disease Annotations
Click to see Annotation Detail View
|
|
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
Gene Ontology Annotations
Click to see Annotation Detail View
Biological Process
|
|
|
Cellular Component
|
|
|
Phenotype Annotations
Click to see Annotation Detail View
Mammalian Phenotype
|
|
|
References
References - curated
| # | Reference Title | Reference Citation |
| 1. | MGDs mouse GO annotations | MGD data from the GO Consortium |
| 2. | Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries. | Okazaki N, etal., DNA Res 2003 Feb 28;10(1):35-48. |
| 3. | Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. | Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73. |
| 4. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
Additional References at PubMed
| PMID:8889548 | PMID:10349636 | PMID:11042159 | PMID:11076861 | PMID:11217851 | PMID:12062803 | PMID:12079279 | PMID:12477932 | PMID:12520002 | PMID:14610273 | PMID:15158073 | PMID:15797708 |
| PMID:16141072 | PMID:16141073 | PMID:16944949 | PMID:17967808 | PMID:18799693 | PMID:21267068 | PMID:21873635 | PMID:23341629 | PMID:23342162 | PMID:24154525 | PMID:24316575 | PMID:24982181 |
| PMID:25065758 | PMID:26671463 | PMID:28671696 | PMID:31138677 | PMID:32079660 | PMID:32497170 | PMID:32541003 | PMID:34321999 | PMID:34708032 | PMID:35352947 | PMID:36417873 | PMID:38172636 |
Genomics
Comparative Map Data
| Nav1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NAV1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nav1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nav1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NAV1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NAV1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nav1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NAV1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NAV1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nav1 (Heterocephalus glaber - naked mole-rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variants
.
Variants in Nav1
8701 total Variants 
|
